DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Jalyn (Dutasteride / Tamsulosin Hydrochloride) - Summary

 
 



JALYN SUMMARY

JALYN (dutasteride and tamsulosin hydrochloride) Capsules contain dutasteride (a selective inhibitor of both the type 1 and type 2 isoforms of steroid alpha-reductase, an intracellular enzyme that converts testosterone to dihydrotestosterone (DHT) and tamsulosin (an antagonist of alpha1A-adrenoceptors in the prostate). Each JALYN Capsule contains the following: One dutasteride oblong, opaque, dull-yellow soft gelatin capsule, containing 0.5 mg of dutasteride dissolved in a mixture of butylated hydroxytoluene and mono-di-glycerides of caprylic/capric acid.

JALYN™ (dutasteride and tamsulosin hydrochloride) Capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.


See all Jalyn indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Jalyn (Dutasteride / Tamsulosin)

Benign Prostatic Hyperplasia (Enlarged Prostate) Quiz
Source: MedicineNet Prostatitis Specialty [2012.02.29]
Title: Benign Prostatic Hyperplasia (Enlarged Prostate) Quiz
Category: MedicineNet Quiz
Created: 2/7/2012 3:29:00 PM
Last Editorial Review: 2/29/2012 6:25:09 PM

Benign Prostatic Hyperplasia
Source: MedicineNet Saw Palmetto Specialty [2008.06.23]
Title: Benign Prostatic Hyperplasia
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 6/23/2008

more news >>

Clinical Trials Related to Jalyn (Dutasteride / Tamsulosin)

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State [Recruiting]
The purpose of this study is to assess the bioequivalence of the second generation dutasteride and tamsulosin hydrochloride (HCL) combination capsule versus currently available commercial combination of dutasteride 0. 5 milligram (mg) and tamsulosin HCL 0. 4 mg capsule in healthy adult male subjects. Subjects in this study will receive either a single oral dose of the second generation dutasteride 0. 5 mg and tamsulosin 0. 4 mg combination capsule or a single dose of commercially available combination of dutasteride 0. 5 mg and tamsulosin HCL 0. 4 mg followed by a 28-day washout period both in fasted state. The study will enroll approximately 92 healthy adult male subjects in order to complete approximately 76 evaluable subjects. The total duration of a subject's involvement in this study is anticipated to be approximately 12 weeks.

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer [Recruiting]
The purpose of this study is see if quality of life is improved in patients receiving oral hormone therapy compared to standard of care. The study will also compare survival rates between patients receiving oral hormone therapy and those receiving standard of care.

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State [Recruiting]
The purpose of this study is to assess the bioequivalence of the second generation dutasteride and tamsulosin hydrochloride (HCL) combination capsule versus currently available commercial combination of dutasteride 0. 5 milligrams (mg) and tamsulosin HCL 0. 4 mg capsule in healthy adult male subjects. Subjects in this study will receive either a single oral dose of the second generation dutasteride 0. 5 mg and tamsulosin 0. 4 mg combination capsule or a single dose of commercially available combination of dutasteride 0. 5 mg and tamsulosin HCL 0. 4 mg capsule followed by a 28-day washout period both in fed state. The study will enroll approximately 92 healthy adult male subjects in order to complete approximately 76 evaluable subjects. The total duration of a subject's involvement in this study is anticipated to be approximately 12 weeks.

more trials >>

Reports of Suspected Jalyn (Dutasteride / Tamsulosin) Side Effects

Drug Ineffective (17)Dizziness (17)Rash (10)Erectile Dysfunction (9)Headache (7)Nocturia (6)Gynaecomastia (6)Oedema Peripheral (6)Dyspnoea (6)Libido Decreased (6)more >>


Page last updated: 2012-02-29

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014